Sotorasib (AMG 510) Shows Promising Results in Some Patients With Solid Tumors, Suggests a Study With City of Hope as a Co-Lead Author

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--A phase 1 clinical trial of AMG 510 in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity.

Click to view original post